RecruitingPhase 3NCT07355218
Rare condition
Discoid lupus erythematosus
5
studies recruiting now
as of 7 Sept 2026
43
studies registered in total
as of 7 Sept 2026
6
countries with a recruiting site
as of 7 Sept 2026
9 Jul 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 3NCT07332481
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
RecruitingPhase 2NCT07694336
A Study of Quinacrine in Participants With Cutaneous Lupus Erythematosus
RecruitingPhase 4NCT06875960
A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
RecruitingPhase 2NCT06261021
Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Discoid lupus erythematosus studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Discoid lupus erythematosus study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Discoid lupus erythematosus
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
10 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 2Secukinumab (Cosentyx)
Phase 2Tanzisertib
Phase 2Daxdilimab
Phase 2Ruxolitinib (Jakavi)
Phase 2Delgocitinib
Phase 2Thalidomide (Kevadon)
Phase 1/2Apremilast (Apremilast accord)
Phase 1Amg-811
+ 2 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).